Brand names
Ruxolitinib brand names
3 brands in 1 markets
Ruxolitinib is sold under 3 brand names in 1 markets in our register data, including Jakafi, Jakafi XR, Opzelura. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Jakafi | United States | Incyte | 10 mg, 15 mg, 20 mg, 25 mg, 5 mgTablet | US FDA NDC directoryChecked 12 November 2026 |
| Jakafi XR | United States | Incyte | 11 mg, 22 mg, 33 mg, 44 mg, 55 mgExtended-release tablet | US FDA NDC directoryChecked 12 November 2026 |
| Opzelura | United States | Incyte | 1.5%Cream | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ruxolitinib for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.